Sign in

You're signed outSign in or to get full access.

Carlos Nueno

President, International at Teladoc HealthTeladoc Health
Executive

About Carlos Nueno

Carlos Nueno, 51, is President, International at Teladoc Health, serving since July 2018. He oversees strategic direction, operations and client management for international markets. He co‑founded and led Advance Medical (1999–2018) and previously worked at Gemini Consulting. He holds an MBA from IESE and a bachelor’s in Industrial and Mechanical Engineering from the Polytechnic University of Catalonia. In 2024, Teladoc delivered $2.6B revenue and $311M adjusted EBITDA (12.1% margin), with International revenue of $410M up 12%, which informed incentive outcomes across executives .

Past Roles

OrganizationRoleYearsStrategic Impact
Teladoc HealthPresident, International2018–presentLeads strategy, operations and client management across international markets
Advance MedicalCo‑founder, CEO1999–2018Built global tele‑medical services; business acquired by Teladoc in 2018
Gemini ConsultingConsultant1999–2000Strategy consulting experience

External Roles

OrganizationRoleYearsStrategic Impact
Barcelona GlobalSupervisory Board MemberCurrentCivic/industry engagement in Barcelona

Fixed Compensation

Metric202320242025
Base Salary (USD)$447,700 $488,103 (set in euros; effective Jan 1, 2024) $564,566 (set in euros)
Target Bonus (% of salary)75% after Aug 2024 (initially 65%)
Actual Annual Cash Bonus (USD)$410,878 (100% of target; paid for 2024 performance)
Retention Bonus (USD)$97,527 (one‑time; granted Apr 26, 2024)
  • 2024 base pay converted from €451,083 at $1.08207/€; in August 2024 the Committee increased salary to €500,000 reflecting expanded responsibilities .
  • 2025 base pay is €521,746 converted using the same $1.08207/€ average as 2024 .

Perquisites (2024):

ItemAmount (USD)
Social security benefit$16,200
Health insurance premiums$6,704
Life insurance premiums$15,488
Company car usage$13,556
Meal allowance$2,880
Tax gross‑ups$30,160

Performance Compensation

Cash bonus architecture (2024):

MetricWeightingTargetActualPayoutVesting
International Segment Results (Revenue, Bonus Margin)100% (Nueno allocation) Not disclosed Not disclosed 100% of target (Nueno) N/A

Long‑term equity (2024 PSU program for NEOs):

PSU MetricWeightingThresholdTargetMaximum2024 PerformancePayoutVesting Schedule
Adjusted EBITDA (2024)40% $328M $395M $462M $311M 0% Would have vested 1/3 on 3/19/2025, 2/3 quarterly from 6/1/2025; none earned
Free Cash Flow (2024)10% $193M $255M $317M $170M 0% Would have vested 1/3 on 3/19/2025, 2/3 quarterly from 6/1/2025; none earned
Revenue (2025)50% Not disclosed Not disclosed 200% cap In progressTBD 2/3 vests 3/1/2026; 1/3 quarterly thereafter

Other PSU outcomes:

  • 2023 Revenue PSUs (performance period ending 2024): not earned (below threshold) .
  • 2022 Adjusted EBITDA Margin PSUs (3‑yr period ending 2024): not earned (12.09% vs 14.75% threshold) .

Equity Ownership & Alignment

Beneficial ownership (as of March 27, 2025):

CategoryShares/Units
Shares owned12,891
Options exercisable within 60 days45,718
RSUs vesting within 60 days
Total beneficial ownership58,609 (less than 1% of class)

Outstanding awards at FY‑end 2024 (Nueno):

Award TypeGrant DateUnvested/Unearned (#)Notes
RSUs (time‑based)3/19/202454,675 RSUs vest 1/3 on first anniversary, then in eight equal quarterly installments
PSUs (Revenue 2025)3/19/202427,337 2/3 vest 3/1/2026; remainder quarterly thereafter (if earned)
PSUs (Adj. EBITDA/FCF 2024)3/19/202427,338 Not earned; would have vested per schedule if achieved
Stock Options6/1/202239,183 exercisable; 7,842 unexercisable; $32.62 strike; exp. 5/31/2032

2024 vesting and realizations:

TypeShares VestedValue Realized (USD)
Stock awards36,038$463,444

Stock ownership governance:

  • Executive stock ownership guidelines: 3x base salary for executive officers (CEO 5x); compliance period applies per role .
  • Insider trading policy prohibits hedging and pledging of company stock .
  • Clawback policy (SEC/NYSE compliant) applies to incentive‑based compensation for restatements over prior 3 years .

Employment Terms

Severance & change‑of‑control (Spain‑based services agreement):

ScenarioCashBenefitsEquity Treatment
Termination without cause / resignation for good reason18 months base salary; prior‑year unpaid bonus Continued benefits up to 18 months (car, computer/phone, private health insurance for executive & family, life insurance) Accelerated vesting of time‑based awards scheduled within next 12 months; performance‑based awards remain eligible if conditions are met during that 12‑month period
Termination in connection with/within 12 months after change in control18 months base salary; prior‑year unpaid bonus; lump‑sum of 75% of target bonus for year of termination Continued benefits up to 18 months Accelerated vesting of time‑based awards; performance‑based awards remain eligible if conditions thereafter satisfied; PSUs earned at ≥ target or based on expected performance at CoC determination

Quantified severance (assuming event on Dec 31, 2024; stock $9.09):

Triggering EventCash Severance (USD)Benefit Continuation (USD)Equity Awards (USD)Total (USD)
Involuntary termination$811,553 $57,944 $451,236 $1,320,732
Change in control (earn‑in of PSUs per plan)$250,194 $250,194
Termination in connection with change in control$1,115,885 $57,944 $1,029,187 $2,203,015

Restrictive covenants:

  • Non‑compete & non‑solicit: 18 months post‑termination (scope defined for international markets) .

Investment Implications

  • Pay‑for‑performance linkage: Nueno’s cash bonus was fully tied to International segment metrics and paid 100% of target for 2024, while company‑wide EBITDA/FCF PSUs paid zero—indicating segment execution but stringent enterprise performance hurdles for equity .
  • Vesting cadence: 54,675 RSUs granted in 2024 vest over three years, with 36,038 shares vested in 2024 across prior awards; periodic vesting can add supply, though hedging/pledging is prohibited by policy .
  • Alignment and risk: Beneficial ownership is modest (<1%); guidelines require 3x salary equity holdings; clawback policy reduces misconduct risk; however, change‑of‑control terms include cash and accelerated equity, and perquisite tax gross‑ups indicate some shareholder‑unfriendly elements in benefits .
  • Governance backdrop: Strong say‑on‑pay support (91.6% in 2022, 81.9% in 2023, 95.9% in 2024) suggests investor acceptance of pay structures; equity awards are performance‑weighted, but recent PSU non‑payouts underline ambitious targets amid mixed macro/commercial conditions .